Abstract:Background: Mitochondria are the 'powerhouses of cells' and progressive mitochondrial dysfunction is a hallmark of aging in skeletal muscle. Although different forms of exercise modality appear to be beneficial to attenuate aging-induced mitochondrial dysfunction, it presupposes that the individual has a requisite level of mobility. Moreover, non-exercise alternatives (i.e., nutraceuticals or pharmacological agents) to improve skeletal muscle bioenergetics require time to be effective in the target tissue and have another limitation in that they act systemically and not locally where needed. Mitochondrial transplantation represents a novel directed therapy designed to enhance energy production of tissues impacted by defective mitochondria. To date, no studies have used mitochondrial transplantation as an intervention to attenuate aging-induced skeletal muscle mitochondrial dysfunction. The purpose of this investigation, therefore, was to determine whether mitochondrial transplantation can enhance skeletal muscle bioenergetics in an aging rodent model. We hypothesized that mitochondrial transplantation would result in sustained skeletal muscle bioenergetics leading to improved functional capacity. Methods: Fifteen female mice (24 months old) were randomized into two groups (placebo or mitochondrial transplantation). Isolated mitochondria from a donor mouse of the same sex and age were transplanted into the hindlimb muscles of recipient mice (quadriceps femoris, tibialis anterior, and gastrocnemius complex). Results: The results indicated significant increases (ranging between ~36% and ~65%) in basal cytochrome c oxidase and citrate synthase activity as well as ATP levels in mice receiving mitochondrial transplantation relative to the placebo. Moreover, there were significant increases (approx. two-fold) in protein expression of mitochondrial markers in both glycolytic and oxidative muscles. These enhancements in the muscle translated to significant improvements in exercise tolerance. Conclusions: This study provides initial evidence showing how mitochondrial transplantation can promote skeletal muscle bioenergetics in an aging rodent model.

Building the case for mitochondrial transplantation as an anti-aging cardiovascular therapy

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Engineered Mitochondrial Transplantation as An Anti-Aging Therapy

Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging

Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases

New insights into vascular aging: Emerging role of mitochondria function

Mitochondria: A Potential Rejuvenation Tool against Aging

Targeting organ-specific mitochondrial dysfunction to improve biological aging

The Role of Endothelial Cell Mitophagy in Age-Related Cardiovascular Diseases

Regulatory Mechanisms of Mitochondrial Function and Cardiac Aging

Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases

Mitochondrial and metabolic dysfunction in ageing and age-related diseases

Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality

Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4+ T Cells in Aging

Mitochondrial Transplantation's Role in Rodent Skeletal Muscle Bioenergetics: Recharging the Engine of Aging

Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease

Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing.

Mitophagy: At the heart of mitochondrial quality control in cardiac aging and frailty

Insights Into the Role of Mitochondria in Vascular Calcification

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease